tiprankstipranks
TipRanksTop Financial ExpertsInsidersEric Dobmeier

Eric Dobmeier Insider Profile

11 Followers
Eric Dobmeier, Director at Structure Therapeutics, Inc. Sponsored ADR, holds ― shares in Structure Therapeutics, Inc. Sponsored ADR (Ticker: GPCR), holds 15.48K shares in Janux Therapeutics Inc (Ticker: JANX), holds ― shares in Jade Biosciences (Ticker: JBIO). Most recently, Eric Dobmeier ― shares of Structure Therapeutics, Inc. Sponsored ADR on ― for an estimated value of ―.
See the Hottest Stocks Based on Insider Trading >
tipranks
Eric Dobmeier

Eric Dobmeier
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
Director

Ranked #10,149 out of 108,921 Corporate Insiders

Profitable Transactions

64%
9 out of 14 Profitable Transactions

Average Return

+15.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$6M
94.73%
4.65%
0.62%
0.00%
0.00% Others
A breakdown of Eric Dobmeier's holdings
See the Top Stocks by Insiders

Insider Roles

Atara Biotherapeutics
(ATRA)
Director
Janux Therapeutics Inc
(JANX)
Director
Adaptive Biotechnologies
(ADPT)
Director
Structure Therapeutics, Inc. Sponsored ADR
(GPCR)
Director
+1 other positions
Roles that Eric Dobmeier holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Chinook Therapeutics
(KDNY)
Rating:Informative Buy
Date:Aug 19, 2021 - Aug 19, 2022
Return:+80.20%
The most profitable trade made by Eric Dobmeier
See the Latest Stocks Traded by Insiders

Eric Dobmeier's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
GPCR
Structure Therapeutics, Inc. Sponsored ADR
―
Director
―
―
JANX
Janux Therapeutics Inc
Jun 12, 2026
Director
Uninformative Buy
―
$273.70K
JBIO
Jade Biosciences
―
Director
―
―
SGEN
Seagen
Aug 30, 2017
―
Uninformative Sell
255.88K
$27.42M
ARAV
Aravive
Dec 22, 2017
―
Uninformative Buy
―
$726.40
ADPT
Adaptive Biotechnologies
Feb 17, 2021
Director
Uninformative Buy
―
$36.44K
KDNY
Chinook Therapeutics
Aug 11, 2023
―
Uninformative Sell
―
$0.00
STML
Stemline Therapeutics
Jun 20, 2017
―
Uninformative Buy
―
$212.50K
ATRA
Atara Biotherapeutics
Nov 14, 2023
Director
Informative Buy
98.30K
$5.57M
List of latest transactions for each holding click on a transaction to see Eric Dobmeier's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Eric Dobmeier insider profile FAQ

What is the percentage of profitable transactions made by Eric Dobmeier?
The percentage of profitable transactions made by Eric Dobmeier is 64%.
    What is the average return per transaction made by Eric Dobmeier?
    The average return per transaction made by Eric Dobmeier is 15.40%.
      What stocks does Eric Dobmeier hold?
      Eric Dobmeier holds: GPCR, JANX, JBIO, SGEN, ARAV, ADPT, KDNY, STML, ATRA stocks.
        What was Eric Dobmeier’s latest transaction?
        Eric Dobmeier latest transaction was an Uninformative Buy of ―.
          What was Eric Dobmeier's most profitable transaction?
          Eric Dobmeier’s most profitable transaction was an Informative Buy of KDNY stock on August 19, 2021. The return on the trade was 80.20%.
            What is Eric Dobmeier's role in Structure Therapeutics, Inc. Sponsored ADR?
            Eric Dobmeier's role in Structure Therapeutics, Inc. Sponsored ADR is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.